BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18302271)

  • 1. Concurrent hyperfractionated radiotherapy and carboplatin with transoral debulking microsurgery for T2N0 glottic cancer.
    Ohguri T; Imada H; Nakano K; Yahara K; Udaka T; Suzuki H; Korogi Y
    Head Neck; 2008 Aug; 30(8):1027-34. PubMed ID: 18302271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis: concurrent chemoradiotherapy and adjuvant chemotherapy for T2N0 glottic squamous cell carcinoma.
    Nonoshita T; Shioyama Y; Kunitake N; Nakamura K; Nomoto S; Ohga S; Toriya Y; Ono M; Honda H
    Fukuoka Igaku Zasshi; 2009 Jan; 100(1):26-31. PubMed ID: 19378773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck.
    Christiansen H; Hermann RM; Martin A; Florez R; Kahler E; Nitsche M; Hille A; Steiner W; Hess CF; Pradier O
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1067-74. PubMed ID: 16750331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison between transoral microsurgery by CO2 laser and conventional surgical therapy for T2 glottic carcinoma].
    Kehrl W; Tolkemitt J; Düsterhus P
    Laryngorhinootologie; 2003 Mar; 82(3):189-94. PubMed ID: 12673518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control.
    Akimoto T; Nonaka T; Kitamoto Y; Ishikawa H; Ninomiya H; Chikamatsu K; Furuya N; Hayakawa K; Mitsuhashi N; Nakano T
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):995-1001. PubMed ID: 16406396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated transoral laser microsurgery for early and advanced recurrence of early glottic cancer after primary laser resection.
    Roedel RM; Matthias C; Wolff HA; Christiansen H
    Auris Nasus Larynx; 2010 Jun; 37(3):340-6. PubMed ID: 19700251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors leading to the use of alternate treatment modalities following transoral laser excision of T1 and T2 glottic squamous cell carcinoma.
    Pham TA; De Freitas R; Sigston E; Vallance N
    ANZ J Surg; 2012 Oct; 82(10):720-3. PubMed ID: 22901105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voice outcomes following transoral laser microsurgery for early glottic squamous cell carcinoma.
    Kennedy JT; Paddle PM; Cook BJ; Chapman P; Iseli TA
    J Laryngol Otol; 2007 Dec; 121(12):1184-8. PubMed ID: 17445355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic laser surgery of early glottic cancer: involvement of the anterior commissure.
    Rödel RM; Steiner W; Müller RM; Kron M; Matthias C
    Head Neck; 2009 May; 31(5):583-92. PubMed ID: 19132720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transoral carbon dioxide laser microsurgery for recurrent glottic carcinoma after radiotherapy.
    Steiner W; Vogt P; Ambrosch P; Kron M
    Head Neck; 2004 Jun; 26(6):477-84. PubMed ID: 15162348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
    Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
    Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent chemoradiotherapy with carboplatin and uracil-ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx.
    Taguchi T; Tsukuda M; Mikami Y; Horiuchi C; Ishitoya JI; Katori H
    J Laryngol Otol; 2006 Jun; 120(6):478-81. PubMed ID: 16563197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma].
    Ikeda Y; Tsukuda M; Tanigaki Y; Yabuki K; Mitake D; Ishitoya J
    Gan To Kagaku Ryoho; 2008 May; 35(5):789-92. PubMed ID: 18487914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carbon dioxide laser transoral microsurgery for glottic carcinoma in situ].
    De Monès E; Hans S; Hartl DM; Laccourreye O; Brasnu D
    Ann Otolaryngol Chir Cervicofac; 2002 Feb; 119(1):21-30. PubMed ID: 11965103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.
    Canis M; Ihler F; Martin A; Wolff HA; Matthias C; Steiner W
    Head Neck; 2014 May; 36(5):652-9. PubMed ID: 23596018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection.
    Chone CT; Yonehara E; Martins JE; Altemani A; Crespo AN
    Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):882-7. PubMed ID: 17875854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transoral laser microsurgery outcomes with early glottic cancer: the Dalhousie University experience.
    Lester SE; Rigby MH; Taylor SM
    J Laryngol Otol; 2011 May; 125(5):509-12. PubMed ID: 21281534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.